IP12-31 THE EFFICACY AND SAFETY OF DISITAMAB VEDOTIN COMBINED WITH IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH METASTATIC UPPER TRACT UROTHELIAL CARCINOMA: A MULTICENTER REAL-WORLD STUDY

Cheoklong Ng, Taile Jing, Shicheng Yu, Jianjun Ye, Shun Zhang, Zhankui Jia, Qi Tang, Xiaoyi Hu, Minfeng Chen, Weiping Huang, Jitao Wu, Hai Bi, Zejun Yan, Haibo Shen, Wei Xiong, Zheng Liu, Jun Xiao, Tao Zhang, Xuedong Wei, Hailong Hu, Qingwu Yang, Yichu Yuan, Zhiyang Huang, Yige Bao, Guoqing Ding, Dan Xia, Jiwei HuangThe Journal of Urology 2025 · DOI

BibTeX
@article{ng2025ip,
  author = {Cheoklong Ng and Taile Jing and Shicheng Yu and Jianjun Ye and Shun Zhang and Zhankui Jia and Qi Tang and Xiaoyi Hu and Minfeng Chen and Weiping Huang and Jitao Wu and Hai Bi and Zejun Yan and Haibo Shen and Wei Xiong and Zheng Liu and Jun Xiao and Tao Zhang and Xuedong Wei and Hailong Hu and Qingwu Yang and Yichu Yuan and Zhiyang Huang and Yige Bao and Guoqing Ding and Dan Xia and Xue Wei and Jiwei Huang},
  title = {{IP12-31 THE EFFICACY AND SAFETY OF DISITAMAB VEDOTIN COMBINED WITH IMMUNE CHECKPOINT INHIBITORS IN PATIENTS WITH METASTATIC UPPER TRACT UROTHELIAL CARCINOMA: A MULTICENTER REAL-WORLD STUDY}},
  journal = {The Journal of Urology},
  year = {2025},
  doi = {10.1097/01.ju.0001109940.79528.1b.31},
}

Loading related content...

Figure